BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 20, 2016
View Archived Issues
Mitochon raises funding to advance MP-101 into clinic
Read More
MacroGenics and Janssen enter collaboration and license agreement to develop MGD-015
Read More
AXIM Biotechnologies launches trials for AX-1602
Read More
Chugai's novel T cell-redirecting antibody targets both CD3 and glypican-3
Read More
Synthon begins second part of SYD-985 clinical trial
Read More
Levels of BAFF and APRIL may be useful as biomarkers of APAP
Read More
Cell and Gene Therapy Catapult and University of Aberdeen create new company, Islexa
Read More
FDA grants priority review to sBLA for Genmab 's ofatumumab
Read More
Enrollment open in phase I study of Lymfactin for breast cancer-associated secondary lymphedema
Read More
Celator's Vyxeos gains FDA breakthrough status for AML
Read More
Repros reports promising data from phase IIb study of oral Proellex
Read More
Enanta Pharmaceuticals patents antihepatitis agents
Read More
Lysosomal Therapeutics discloses beta-glucocerebrosidase activators
Read More
Bicycle Therapeutics describes anticancer agents
Read More
NIH-funded phase IIb/III trial to evaluate HIV vaccine regimen in South Africa
Read More
Zealand Pharma reports development of GIPR receptor agonists
Read More
JNJ-61178104 begins phase I study under Genmab and Janssen's DuoBody collaboration
Read More
Sanofi presents mitochondrial complex I inhibitors
Read More
Pelican Therapeutics wins NCPD award for the development of TNFRSF25 agonists
Read More
Results from phase I study of RG-7716 for wet AMD
Read More
Abpro signs agreements with Massachusetts General Hospital and Brigham and Women's Hospital
Read More
VASH2 shows promise as a therapeutic target for CRPC
Read More
Novartis establishes global clinical program for heart failure Fortihfy
Read More
Biocept launches liquid biopsy test to detect RET oncogene fusions
Read More
Neurotrope enters collaboration with IRSF to study bryostatin in Rett syndrome
Read More
Beta launch of spinal deformity molecular diagnostic test
Read More
Eureka Therapeutics CAR-T therapy targeting antigen/MHC complexes to enter phase I
Read More
NLRP3-inflammasome responses show potential as therapeutic targets for SSI asthma
Read More
Merrimack begins biomarker-based phase I trial of MM-151 in cancer
Read More